If you own or are considering buying pharma laggards Pfizer ( PFE +1.42%), Bristol Myers Squibb ( BMY +0.26%), and Merck ( ...

Pfizer stock offers 30% upside with strong non-COVID franchises, margin expansion, and pipeline potential. Click here to read ...

Pfizer Inc. (NYSE:PFE) is one of the stocks Jim Cramer was recently asked about. During the episode, a caller inquired if the ...

Fintel reports that on December 2, 2025, Citigroup reiterated coverage of Pfizer (NYSE:PFE) with a Neutral recommendation.

Pfizer (PFE) shares have shown some movement this week, drawing attention for investors evaluating the company’s current ...

The Prudent Speculator is an investment newsletter that has been published monthly since 1977. Buckingham and his team run four value-stock portfolios. The flagship Prudent Speculator Portfolio has ...

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

Worries about regulatory headwinds weighed on vaccine producers on Monday, Dec. 1, 2025, while a chip design software maker got a boost from a partnership with an AI darling.

Amgen's nearly 16% surge follows strong Q3 results, raised sales guidance and growing momentum across key drugs and biosimilars.

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ...

If you are looking to own a stock for the long term, these out-of-favor drugmakers have proven they have what it takes to ...

To get a sense of who is truly in control of Pfizer Inc. (NYSE:PFE), it is important to understand the ownership structure of ...